MENORA MIVTACHIM HOLDINGS LTD.MENORA MIVTACHIM HOLDINGS LTD.

Institutional investor · Portfolio as of Q4 2024

SEC EDGAR SourceSEC Filings

Top Holdings99 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

APPLE INC

5M$1.3B7.8%$147.04+69.08%
24 qtrssince 2019-Q1
Decreased
0

MICROSOFT CORP

2.9M$1.2B7.8%$228.73+84.37%
24 qtrssince 2019-Q1
Decreased
0

ALPHABET INC-CL A

4.7M$885.1M5.5%$100.48+89.59%
24 qtrssince 2019-Q1
Decreased
0

NVIDIA CORP

6.4M$864.3M5.4%$118.81+15.69%
24 qtrssince 2019-Q1
Increased
71

AMAZON.COM INC

3M$653.2M4.1%$127.08+74.14%
24 qtrssince 2019-Q1
Increased
61
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

28.4M$625.5M3.9%$9.50+134.92%
21 qtrssince 2019-Q4
Decreased
0

META PLATFORMS INC-CLASS A

1M$614.4M3.9%$273.15+115.77%
19 qtrssince 2020-Q2
Decreased
0
FLINFLIN
ETF

FRANKLIN TEMPLETON ETF TR

11.2M$423M2.7%$33.47+12.17%
7 qtrssince 2023-Q2
Increased
57
XLPXLP
ETF

CONSUMER STAPLES SPDR

4.6M$365.4M2.3%$76.33-0.05%
8 qtrssince 2023-Q1
Increased
79

MASTERCARD INC - A

690,260$363.5M2.3%$341.13+52.95%
16 qtrssince 2021-Q1
Decreased
0

JPMORGAN CHASE & CO

1.5M$355.8M2.2%$146.85+58.88%
6 qtrssince 2023-Q3
Decreased
0
XLUXLU
ETF

UTILITIES SELECT SECTOR SPDR

3.9M$296.5M1.9%$37.79-2.53%
8 qtrssince 2023-Q1
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

1.5M$295.6M1.9%$94.09+110.15%
9 qtrssince 2022-Q4
Decreased
0
NICENICE
ADR

NICE LTD - SPON ADR

1.7M$281.9M1.8%$182.26-6.44%
4 qtrssince 2024-Q1
Increased
50
VOOVOO
ETF

VANGUARD S&P 500 ETF

523,233$281.9M1.8%$531.27+0.59%
8 qtrssince 2023-Q1
Increased
78

ABBVIE INC

1.6M$276.6M1.7%$117.44+42.82%
19 qtrssince 2020-Q2
Unchanged
0

APPLIED MATERIALS INC

1.7M$275.8M1.7%$122.44+31.18%
16 qtrssince 2021-Q1
Decreased
0
XLIXLI
ETF

INDUSTRIAL SELECT SECT SPDR

2M$260.1M1.6%$130.04+0.07%
5 qtrssince 2023-Q4
Increased
78
IGVIGV
ETF

ISHARES EXPANDED TECH-SOFTWA

2.6M$259M1.6%$100.940.00%
1 qtr
New
70

HOME DEPOT INC

654,232$254.5M1.6%$301.26+26.12%
24 qtrssince 2019-Q1
Decreased
0
$16B
AUM
99
Positions
Q4 2024
Filing
Rating · 3.5
Quarterly Portfolio Change
+2%Q3'23$11B+8%Q4'23$11.9B+12%Q1'24$13.3B+10%Q2'24$14.7B+8%Q3'24$15.9B+1%Q4'24$16B
Activity profile
$ moved · Q4'24
New20%Increased25%Decreased43%Exited12%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.6 years
<1Q9%1-4Q14%1-2Y35%2Y+41%

MENORA MIVTACHIM HOLDINGS LTD. manages $16B across 99 positions as of Q4 2024. Top holdings: AAPL (7.8%), MSFT (7.8%), GOOGL (5.5%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q4 2024 Summary

Active quarter - 11 new positions, 7 exits, 22 increased. Top move: XLP (INCREASED, conviction 79). Portfolio: $16.0B across 99 positions.

Top holdings by portfolio weight

Total AUM$16B
AAPL7.84%
MSFT7.76%
GOOGL5.55%
NVDA5.42%
AMZN4.09%
TEVA3.92%
META3.85%
FLIN2.65%
XLP2.29%
MA2.28%
Other2.23%

Portfolio allocation by GICS sector

Sectors11
Technology34.38%
Unknown17.55%
Financial Services10.56%
Healthcare10.34%
Communication Services9.56%
Consumer Cyclical9.27%
Industrials3.78%
Consumer Defensive2.31%
Real Estate1.29%
Basic Materials0.86%
Other0.10%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Unknown, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record72
Conviction45
Concentration62
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
TEVATEVATEVA PHARMACEUTICAL-SP ADR
Q1 2025 Q2 2026+11.5M shares+$724.7M
5Q
KREKRESPDR SERIES TRUST
Q2 2025 Q2 2026+3.3M shares+$248M
4Q
QQQQQQINVESCO QQQ TRUST SERIES 1 CL USD INC
Q3 2025 Q2 2026+10,060 shares+$9.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used